Table 3 Independent predictive power of the 6-mRNA model in HCC patients
From: A genomic-clinicopathologic nomogram for predicting overall survival of hepatocellular carcinoma
Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | HR (95% CI) | P value | HR | HR (95% CI) | P value | |
6-mRNA risk Score | 1.1109 | 1.0837–1.1388 | 1.03E-16*** | 1.1031 | 1.0717–1.1355 | 3.00E-11*** |
Age | 1.0200 | 0.9719–1.0330 | 0.8985 | 1.0054 | 0.9716–1.0405 | 0.7558 |
Sex (Male/ Female) | 0.5185 | 0.2782–0.9664 | 0.0387* | 0.3381 | 0.1742–0.6564 | 0.0014* |
Stage (G1/ G2/ G3/ G4) | 2.1546 | 1.4929–3.1098 | 4.13E-05*** | 1.9287 | 1.2998–2.8619 | 0.0011* |
Prior Malignancy (No/ Yes) | 1.7510 | 0.7733–3.9648 | 0.1791 | 2.5483 | 1.0741–6.0459 | 0.0338* |